(E)-Ethyl-2-(2-Chlorobenzylidene)-4-(1,3-dioxoisoindolin-2-yl)-3-oxobutanoate
Levamlodipine M4 Metabolite Sodium is listed by Simson Pharma as a metabolites for laboratory research, analytical development and quality-control workflows.
Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.
Levamlodipine M4 Metabolite Sodium for method validation Levamlodipine M4 Metabolite Sodium reference standard Levamlodipine M4 Metabolite Sodium for ANDA filing Levamlodipine M4 Metabolite Sodium for forced degradation studies Levamlodipine M4 Metabolite Sodium identification standard Levamlodipine M4 Metabolite Sodium for DMF filing Levamlodipine M4 Metabolite Sodium HPLC standard Levamlodipine M4 Metabolite Sodium supplier Levamlodipine M4 Metabolite Sodium manufacturer Levamlodipine M4 Metabolite Sodium distributor
